ストックスクリーナーアプリを入手
26.50
2.40%
0.62
アフターアワーズ：
26.44
-0.06
-0.23%
Pfizer Inc (PFE) 最新ニュース
Pfizer Reshapes Pipeline With Novavax Deal And ViiV Exit - simplywall.st
Pfizer (PFE) Among Firms Facing Medicare Drug Price Negotiations - GuruFocus
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider - Yahoo! Finance Canada
US names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - marketscreener.com
US names HIV, arthritis drugs for next Medicare price talks - Reuters
What are Wall Street analysts' target price for Pfizer stock? - MSN
US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - Yahoo! Finance Canada
The Analyst Verdict: Pfizer In The Eyes Of 7 Experts - Benzinga
Pfizer (PFE) Analyst Rating Update: Cantor Fitzgerald Raises Pri - GuruFocus
Why Is Pfizer Stock Rising Tuesday? - Benzinga
Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's DrugAclaris Therapeutics (NASDAQ:ACRS) - Benzinga
Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline - Finviz
CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines - Law360
Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR - GlobeNewswire Inc.
118,500 Shares in Pfizer Inc. $PFE Acquired by Y Intercept Hong Kong Ltd - MarketBeat
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively - Yahoo Finance
Macrolide Antibiotics Market to Witness Stunning Growth - openPR.com
Pfizer vs. Merck Stock And JNJ - Forbes
With 66% Ownership of the Shares, Pfizer Inc. (NYSE:PFE) Is Heavily Dominated by Institutional Owners - 富途牛牛
Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance (NYSE:PFE) - Seeking Alpha
What Are Wall Street Analysts' Target Price for Pfizer Stock? - Barchart.com
Pfizer (PFE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Pfizer Recasts Infectious Disease Focus With ViiV Exit And Matrix M Access - simplywall.st
Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch - TipRanks
Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock - Benzinga
Pfizer Stock Forecast 2026–2030 | Future Outlook - Capital.com
Parthenon LLC Has $1.27 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Corticosteroids Market Report 2026 - GlobeNewswire Inc.
Callahan Advisors LLC Acquires 43,454 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Avantax Planning Partners Inc. - MarketBeat
Pfizer to exit ViiV Healthcare as GSK and Shionogi reshape ownership - MSN
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership - Yahoo Finance
Quilter Plc Cuts Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Sector Gamma AS Increases Stake in Pfizer Inc. $PFE - MarketBeat
UniSuper Management Pty Ltd Increases Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Commerzbank Aktiengesellschaft FI Increases Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Refines Vaccine Toolkit With Matrix M Deal And ViiV Exit - simplywall.st
The Best Stocks to Invest $40 in to Start the New Year Off Right - Finviz
Pfizer Inc. $PFE Stock Position Lessened by Resona Asset Management Co. Ltd. - MarketBeat
Rakuten Investment Management Inc. Buys New Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Refocuses Portfolio With Matrix M Deal And ViiV Exit - simplywall.st
Lobbying Update: $2,810,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative
Pfizer (NYSE:PFE) Stock Price Down 1.7%Here's What Happened - MarketBeat
Asia roundup: Shionogi ups Viiv stake, Fosun spinoff plans, more - BioWorld MedTech
Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research - Benzinga
Pfizer’s New Autoimmune Candidate PF-08065010 Enters Phase 1: What Investors Should Watch - TipRanks
Pfizer Takes Aim at Keytruda in New Phase 3 Lung Cancer Study: What Investors Should Know - TipRanks
Pfizer Advances New COPD Candidate Into Phase 2/3, Adding Depth to Its Post-COVID Pipeline - TipRanks
Pfizer: Expect Another Double Beating For Q1 (Earnings Preview) (NYSE:PFE) - Seeking Alpha
The Top Stock to Buy With $30 for 2026 - Finviz
Pfizer Inc. $PFE Shares Purchased by Teacher Retirement System of Texas - MarketBeat
Lockheed Martin Investment Management Co. Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Position Raised by Strs Ohio - MarketBeat
Oncolytic Virotherapy Market - GlobeNewswire Inc.
Will Licensing Novavax’s Matrix-M Adjuvant Reshape Pfizer’s (PFE) Vaccine Platform Strategy? - Yahoo Finance
Pfizer (PFE) Valuation Check As Shares Recover Modestly From Longer Term Weakness - simplywall.st
Pfizer Target of Unusually High Options Trading (NYSE:PFE) - MarketBeat
Pfizer Advances PF-07248144 With New Drug–Interaction Study, Signaling Quiet Pipeline Progress - TipRanks
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s ‘Anti-Science’ Vaccine Policies - BioSpace
How Is The Market Feeling About Pfizer Inc? - Benzinga
Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap? - Finviz
NVAX Stock Rises Pre-Market As Pfizer Licenses Its Vaccine Technology - Stocktwits
Analysts Favor Novavax Over Moderna After $30M Pfizer Licensing Deal - Intellectia AI
2.32%
1.70%
大文字化:
|
ボリューム (24 時間):